Why the study?
Does blood transfusion affect all-cause mortality in adult patients with myocardial infarction?
Does blood transfusion affect all-cause mortality in adult patients with myocardial infarction?
In patients with myocardial infarction, blood transfusion is associated with a significantly increased risk of both short-term and long-term all-cause mortality.
Suggests restrictive transfusion strategies may be safer in myocardial infarction; leaves open whether this association reflects.
// Zuomin Yin 1 , Botao Yu 1 , Weisheng Liu 1 and Ketao Lan 1 1 Department of Chest Pain Center, The Affiliated Central Hospital of Qingdao University, Qingdao, Shandong Province, China Correspondence to: Ketao Lan, email: ketaolan123@126.com Keywords: blood transfusion, myocardial infarction, mortality, meta-analysis Received: June 13, 2017 Accepted: June 29, 2017 Published: July 12, 2017 ABSTRACT Background: Several observational and preclinical studies have shown that blood transfusion may modify the mortality of patients with myocardial infarction (MI). The aim of this meta-analysis is to evaluate the recent evidence on the effectiveness of blood transfusion for all-cause mortality in patients with MI. Materials and Methods: PUBMED, EMBASE and the Cochrane central register of controlled trials were searched up to June 2016 by two independent investigators. Studies were considered eligible if they recruited adult MI patients and reported hazard ratio (HR) for all-cause mortality comparing those who received blood transfusion with those who did not receive blood transfusion. We abstracted and calculated pooled HRs using a random-effects model. Results: From 4277 unique reports, we identified 17 studies including 260811 patients with 11 studies examining short-term (in hospital/30-day) all-cause mortality and 9 studies examining long-term (more than 30 days) all-cause mortality. Meta-analysis demonstrated that patients treated with blood transfusion had increased short-term all-cause mortality (HR, 2.39, 95% CI 1.81 to 3.15) compared with those without blood transfusion treatment. Similar findings were observed by subgroup analyses. We also find significant association between blood transfusion and long-term all-cause mortality (HR 1.90, 95% CI 1.40 to 2.58) for MI patients. Conclusions: In patients with MI, blood transfusion treatment is associated with patient short-term and long-term all-cause mortality. However, further large-scale prospective studies are needed to establish its validity of this association.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: